Literature DB >> 1701452

Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.

W J van Venrooij1, R Hoet, J Castrop, B Hageman, I W Mattaj, L B van de Putte.   

Abstract

Small nuclear ribonucleoprotein (snRNP) particles are a class of RNA-containing particles in the nucleus of eukaryotic cells. Sera from patients with connective tissue diseases often contain antibodies against the proteins present in these snRNPs. Antibodies against the RNA components of snRNPs, the U snRNAs, are thought to be rare. We tested 118 anti-snRNP sera for the presence of anti-snRNA antibodies and found them in 45 sera (38%). In all sera the antibodies (IgG and F(ab)2 fragments thereof) were exclusively directed against U1 snRNA. The anti-(U1) RNA antibodies were always accompanied by anti-(U1)RNP antibodies but were not found in sera which contain antibodies of the Sm serotype directed against all nucleoplasmic U snRNP particles. Like anti-RNP antibodies, anti-U1 RNA activity is confined to sera from patients with SLE or SLE overlap syndromes and is rarely found in patients with other connective tissue diseases. By analyzing binding to subfragments of U1 snRNA made in vitro, it was demonstrated that anti-(U1)RNA antibodies recognize epitopes distributed throughout the U1 RNA molecule. In most sera, however, either the second or the fourth hairpin loop is the main target of the antibody. The possible mechanisms that could lead to the production of this new type of autoantibody are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701452      PMCID: PMC329856          DOI: 10.1172/JCI114954

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

Review 1.  Structure and function of La and Ro RNPs.

Authors:  G J Pruijn; R L Slobbe; W J Van Venrooij
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

2.  Major determinants of the specificity of interaction between small nuclear ribonucleoproteins U1A and U2B'' and their cognate RNAs.

Authors:  D Scherly; W Boelens; N A Dathan; W J van Venrooij; I W Mattaj
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

Review 3.  Small nuclear RNA associated proteins: autoantigens in connective tissue diseases.

Authors:  W J Van Venrooij; P T Sillekens
Journal:  Clin Exp Rheumatol       Date:  1989 Nov-Dec       Impact factor: 4.473

4.  Electron microscopy of small nuclear ribonucleoprotein (snRNP) particles U2 and U5: evidence for a common structure-determining principle in the major U snRNP family.

Authors:  B Kastner; M Bach; R Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  U1 small nuclear RNA from Schizosaccharomyces pombe has unique and conserved features and is encoded by an essential single-copy gene.

Authors:  G Porter; P Brennwald; J A Wise
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Antibodies to RNA from autoimmune NZB/NZW mice recognize a similar antigenic determinant and show a large idiotypic diversity.

Authors:  D Eilat; M Hochberg; R Fischel; R Laskov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.

Authors:  W J Habets; D J de Rooij; M H Hoet; L B van de Putte; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

8.  Multiple domains of U1 snRNA, including U1 specific protein binding sites, are required for splicing.

Authors:  J Hamm; N A Dathan; D Scherly; I W Mattaj
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

9.  Identification of the RNA binding segment of human U1 A protein and definition of its binding site on U1 snRNA.

Authors:  D Scherly; W Boelens; W J van Venrooij; N A Dathan; J Hamm; I W Mattaj
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

10.  U2 RNA shares a structural domain with U1, U4, and U5 RNAs.

Authors:  C Branlant; A Krol; J P Ebel; E Lazar; B Haendler; M Jacob
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  24 in total

1.  Use of epitope tags for routine analysis of transgene expression.

Authors:  C M Alarcon; A R Umthun; J C Register
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

2.  RNA sequences that work as transcriptional activating regions.

Authors:  Shamol Saha; Aseem Z Ansari; Kevin A Jarrell; Mark Ptashne; Kevin A Jarell
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

Review 3.  B-cell epitopes of autoantigenic DNA-binding proteins.

Authors:  C H Chou; M Satoh; J Wang; W H Reeves
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

4.  In vitro selection of an RNA epitope immunologically cross-reactive with a peptide.

Authors:  D E Tsai; D J Kenan; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 5.  Mapping of epitopes recognized by anti-(U1)RNP autoantibodies.

Authors:  H H Guldner
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 6.  B-cell epitopes of RNA autoantigens.

Authors:  R M Hoet; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

7.  Crystal structure of an RNA polymerase ribozyme in complex with an antibody fragment.

Authors:  Joseph A Piccirilli; Yelena Koldobskaya
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-27       Impact factor: 6.237

8.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

9.  Characterization of an anti-RNA recombinant autoantibody fragment (scFv) isolated from a phage display library and detailed analysis of its binding site on U1 snRNA.

Authors:  S W Teunissen; M H Stassen; G J Pruijn; W J van Venrooij; R M Hoet
Journal:  RNA       Date:  1998-09       Impact factor: 4.942

Review 10.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.